Profund Advisors’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-26,743
| Closed | -$2.27M | – | 1253 |
|
|
2019
Q4 | $2.27M | Buy |
26,743
+1,327
| +5% | +$88.5K | 0.1% | 180 |
|
|
2019
Q3 | $1.27M | Buy |
25,416
+2,747
| +12% | +$110K | 0.06% | 273 |
|
|
2019
Q2 | $827K | Buy |
22,669
+9,179
| +68% | +$300K | 0.04% | 426 |
|
|
2019
Q1 | $377K | Sell |
13,490
-6,040
| -31% | -$142K | 0.02% | 785 |
|
|
2018
Q4 | $374K | Sell |
19,530
-5,384
| -22% | -$125K | 0.02% | 629 |
|
|
2018
Q3 | $745K | Buy |
24,914
+9,735
| +64% | +$367K | 0.03% | 529 |
|
|
2018
Q2 | $557K | Buy |
15,179
+1,033
| +7% | +$33.6K | 0.02% | 707 |
|
|
2018
Q1 | $466K | Buy |
14,146
+1,932
| +16% | +$60.4K | 0.02% | 847 |
|
|
2017
Q4 | $334K | Sell |
12,214
-990
| -7% | -$30.5K | 0.01% | 1067 |
|
|
2017
Q3 | $489K | Sell |
13,204
-1,821
| -12% | -$67.1K | 0.02% | 775 |
|
|
2017
Q2 | $571K | Sell |
15,025
-2,115
| -12% | -$94.2K | 0.03% | 654 |
|
|
2017
Q1 | $838K | Sell |
17,140
-3,932
| -19% | -$179K | 0.04% | 534 |
|
|
2016
Q4 | $715K | Buy |
21,072
+5,597
| +36% | +$199K | 0.03% | 641 |
|
|
2016
Q3 | $584K | Buy |
15,475
+1,306
| +9% | +$49.2K | 0.03% | 677 |
|
|
2016
Q2 | $477K | Buy |
14,169
+135
| +1% | +$4.76K | 0.02% | 825 |
|
|
2016
Q1 | $446K | Buy |
14,034
+3,349
| +31% | +$109K | 0.02% | 820 |
|
|
2015
Q4 | $399K | Buy |
10,685
+2,386
| +29% | +$90.2K | 0.02% | 771 |
|
|
2015
Q3 | $315K | Sell |
8,299
-3,963
| -32% | -$139K | 0.02% | 801 |
|
|
2015
Q2 | $351K | Sell |
12,262
-2,193
| -15% | -$61.1K | 0.01% | 1014 |
|
|
2015
Q1 | $405K | Buy |
14,455
+4,146
| +40% | +$116K | 0.02% | 1044 |
|
|
2014
Q4 | $285K | Buy |
10,309
+760
| +8% | +$18.8K | 0.01% | 1161 |
|
|
2014
Q3 | $213K | Sell |
9,549
-6,303
| -40% | -$160K | 0.01% | 1197 |
|
|
2014
Q2 | $461K | Buy |
15,852
+321
| +2% | +$8.57K | 0.02% | 961 |
|
|
2014
Q1 | $441K | Sell |
15,531
-5,680
| -27% | -$188K | 0.02% | 959 |
|
|
2013
Q4 | $819K | Buy |
21,211
+6,131
| +41% | +$219K | 0.04% | 655 |
|
|
2013
Q3 | $505K | Buy |
15,080
+3,796
| +34% | +$121K | 0.03% | 910 |
|
|
2013
Q2 | $347K | Buy |
+11,284
| New | +$378K | 0.02% | 860 |
|
Other funds holding MDCO
Profund Advisors's MDCO Position: Q1 2020 in Review
Profund Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 26,743 shares — an estimated $2.27M sold.
Profund Advisors first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $2.27M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Profund Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Profund Advisors sold 26,743 Medicines Co shares in Q1 2020, an estimated $2.27M.
- Profund Advisors first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Profund Advisors's Medicines Co position peaked at $2.27M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Profund Advisors's 13F filing for Q1 2020, filed 15 May 2020.